Janus Henderson Group’s Vera Therapeutics VERA Stock Holding History

Janus Henderson Group’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$710K	Buy	17,658 +3,723	+27%	+$160K	﹤0.01%	1842
2025 Q4	$705K	Sell	13,935 -7,800	-36%	-$277K	﹤0.01%	1858
2025 Q3	$632K	Hold	21,735	–	–	﹤0.01%	1898
2025 Q2	$512K	Hold	21,735	–	–	﹤0.01%	1939
2025 Q1	$579K	Hold	21,735	–	–	﹤0.01%	1882
2024 Q4	$919K	Buy	21,735 +7,235	+50%	+$320K	﹤0.01%	1733
2024 Q3	$641K	Hold	14,500	–	–	﹤0.01%	1912
2024 Q2	$524K	Sell	14,500 -180	-1%	-$7.14K	﹤0.01%	1960
2024 Q1	$633K	Buy	14,680 +40	+0.3%	+$1.43K	﹤0.01%	1893
2023 Q4	$225K	Buy	+14,640	New	+$186K	﹤0.01%	2390

Other funds holding VERA

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group's VERA Position: Q1 2026 in Review

Janus Henderson Group increased its Vera Therapeutics (VERA) stake by 27% in Q1 2026, buying an estimated $160K and bringing the position to 17,658 shares worth $710K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Janus Henderson Group first reported a position in VERA in Q4 2023 and has held it in 10 quarters since. The position peaked at $919K in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

Janus Henderson Group held 17,658 shares of Vera Therapeutics worth $710K as of Q1 2026.
Janus Henderson Group bought 3,723 Vera Therapeutics shares in Q1 2026, an estimated $160K.
Vera Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1842 holding.
Janus Henderson Group first reported a position in Vera Therapeutics in Q4 2023 and has held it in 10 quarters since.
Janus Henderson Group's Vera Therapeutics position peaked at $919K in Q4 2024.
229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.